Like A ‘GLP-1’ For Muscles And Cartilage?
Researchers Regrew Knee Cartilage In Mice. Now A Biotech Is Doing Clinical Trials.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
More in Finance & Markets
Klarna and FreshBooks partner to bring flexible payments to U.S. and Canadian small businesses and the customers they serve
New York, Oct. 21, 2026 (GLOBE NEWSWIRE) — Klarna, the everyday finance network, today announced a new partnership with FreshBooks, small business management software built for service-based…
Storm Austen Will Be Stronger Than Forecast Along UK Coasts
Britain’s first named storm of the autumn will be stronger than previously thought when it sweeps across the country later this week.
Global Commercial Insurance Rates Drop 5% in Q3; Signs of Stabilization
Commercial insurance rates fell globally for the ninth straight quarter during the third quarter of 2026. According to the latest Global Insurance Market Index released by Marsh, global commercial…
Apple vs. Intel: Which Tech Stock Is a Better Buy in 2026?
Apple's $98.8 billion free cash flow machine faces execution risks, while Intel's turnaround hinges on foundry success, and their valuations tell starkly different stories.
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?
AbbVie's revenue lead has widened to $4 billion per quarter, but Bristol Myers shows surprising resilience despite slower growth.
MSCI: 3 Key Takeaways for Long-Term Investors
Key PointsTotal revenue grew 12.4% in the third quarter.